| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $54.31 | 09 Dec 2025 | Direct |
| Disc Medicine, Inc. | Director | Common Stock | 0 | $0 | $65.33 | 02 Dec 2024 | Direct |
| Ventyx Biosciences, Inc. | Director | Stock Option (Right to Buy) | 40,000 | 05 Jun 2025 | Direct | ||
| Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 10,000 | 11 Jun 2025 | Direct | ||
| Akero Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2025 | 18 | $0 | 4 | Chief Financial Officer | 09 Dec 2025, 10:11 |
| AKRO | Akero Therapeutics, Inc. | 11 Sep 2025 | 1 | -$28,350 | 4 | Chief Financial Officer | 12 Sep 2025, 20:38 |
| AKRO | Akero Therapeutics, Inc. | 30 Jun 2025 | 1 | +$21,243 | 4 | Chief Financial Officer | 02 Jul 2025, 18:00 |
| AKRO | Akero Therapeutics, Inc. | 18 Jun 2025 | 1 | -$89,609 | 4 | Chief Financial Officer | 20 Jun 2025, 21:07 |
| IRON | Disc Medicine, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 17:32 |
| AKRO | Akero Therapeutics, Inc. | 10 Jun 2025 | 1 | -$151,402 | 4 | Chief Financial Officer | 12 Jun 2025, 18:33 |
| VTYX | Ventyx Biosciences, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 15:06 |
| AKRO | Akero Therapeutics, Inc. | 12 Mar 2025 | 1 | -$30,339 | 4 | Chief Financial Officer | 14 Mar 2025, 20:24 |
| AKRO | Akero Therapeutics, Inc. | 16 Dec 2024 | 2 | $0 | 4 | Chief Financial Officer | 18 Dec 2024, 20:59 |
| AKRO | Akero Therapeutics, Inc. | 10 Dec 2024 | 1 | -$86,735 | 4 | Chief Financial Officer | 12 Dec 2024, 20:26 |
| IRON | Disc Medicine, Inc. | 02 Dec 2024 | 7 | -$119,854 | 4 | Director | 04 Dec 2024, 19:43 |
| IRON | Disc Medicine, Inc. | 01 Nov 2024 | 8 | -$99,500 | 4 | Director | 05 Nov 2024, 19:16 |
| IRON | Disc Medicine, Inc. | 01 Oct 2024 | 6 | -$8,331 | 4 | Director | 03 Oct 2024, 16:29 |
| AKRO | Akero Therapeutics, Inc. | 10 Sep 2024 | 1 | -$16,729 | 4 | Chief Financial Officer | 13 Sep 2024, 17:13 |
| IRON | Disc Medicine, Inc. | 03 Sep 2024 | 8 | -$90,523 | 4 | Director | 05 Sep 2024, 16:06 |
| AKRO | Akero Therapeutics, Inc. | 26 Aug 2024 | 12 | -$1,073,160 | 4 | Chief Financial Officer | 29 Aug 2024, 16:30 |
| IRON | Disc Medicine, Inc. | 01 Aug 2024 | 4 | -$6,749 | 4 | Director | 05 Aug 2024, 16:15 |
| AKRO | Akero Therapeutics, Inc. | 23 Jul 2024 | 11 | -$3,247,425 | 4 | Chief Financial Officer | 25 Jul 2024, 17:54 |
| AKRO | Akero Therapeutics, Inc. | 16 Jul 2024 | 4 | -$767,385 | 4 | Chief Financial Officer | 18 Jul 2024, 21:41 |
| IRON | Disc Medicine, Inc. | 01 Jul 2024 | 5 | -$7,271 | 4 | Director | 03 Jul 2024, 16:15 |
| IRON | Disc Medicine, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:15 |
| AKRO | Akero Therapeutics, Inc. | 11 Jun 2024 | 1 | -$64,094 | 4 | Chief Financial Officer | 13 Jun 2024, 18:09 |
| VTYX | Ventyx Biosciences, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:32 |
| IRON | Disc Medicine, Inc. | 03 Jun 2024 | 7 | -$63,973 | 4 | Director | 05 Jun 2024, 16:05 |
| IRON | Disc Medicine, Inc. | 01 May 2024 | 4 | -$3,773 | 4 | Director | 03 May 2024, 16:05 |
| IRON | Disc Medicine, Inc. | 11 Apr 2024 | 6 | -$68,826 | 4 | Director | 15 Apr 2024, 18:27 |
| AKRO | Akero Therapeutics, Inc. | 13 Mar 2024 | 1 | -$20,511 | 4 | Chief Financial Officer | 15 Mar 2024, 16:44 |
| VTYX | Ventyx Biosciences, Inc. | 21 Jan 2024 | 1 | $0 | 4 | Director | 23 Jan 2024, 17:23 |
| AKRO | Akero Therapeutics, Inc. | 14 Dec 2023 | 1 | -$12,684 | 4 | Chief Financial Officer | 18 Dec 2023, 20:40 |
| IRON | Disc Medicine, Inc. | 12 Dec 2023 | 10 | -$1,914,356 | 4 | Director | 14 Dec 2023, 16:15 |
| AKRO | Akero Therapeutics, Inc. | 08 Dec 2023 | 2 | $0 | 4 | Chief Financial Officer | 12 Dec 2023, 16:43 |
| AKRO | Akero Therapeutics, Inc. | 09 Nov 2023 | 1 | $0 | 4 | Chief Financial Officer | 13 Nov 2023, 17:37 |
| AKRO | Akero Therapeutics, Inc. | 13 Sep 2023 | 1 | -$31,815 | 4 | Chief Financial Officer | 25 Sep 2023, 21:31 |
| AKRO | Akero Therapeutics, Inc. | 20 Jun 2023 | 3 | -$1,020,078 | 4 | Chief Financial Officer | 22 Jun 2023, 17:20 |
| AKRO | Akero Therapeutics, Inc. | 13 Jun 2023 | 1 | -$33,427 | 4 | Chief Financial Officer | 15 Jun 2023, 21:41 |
| IRON | Disc Medicine, Inc. | 09 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 18:16 |
| VTYX | Ventyx Biosciences, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:45 |
| AKRO | Akero Therapeutics, Inc. | 10 Mar 2023 | 1 | -$27,864 | 4 | Chief Financial Officer | 14 Mar 2023, 16:25 |
| VTYX | Ventyx Biosciences, Inc. | 23 Jan 2023 | 5 | -$969,473 | 4 | Director | 24 Jan 2023, 17:33 |
| IRON | Disc Medicine, Inc. | 29 Dec 2022 | 1 | $0 | 4 | Director | 03 Jan 2023, 16:05 |
| IRON | Disc Medicine, Inc. | 29 Dec 2022 | 0 | $0 | 3 | Director | 03 Jan 2023, 16:00 |
| AKRO | Akero Therapeutics, Inc. | 27 Dec 2022 | 6 | -$855,143 | 4 | Chief Financial Officer | 29 Dec 2022, 16:41 |
| AKRO | Akero Therapeutics, Inc. | 16 Dec 2022 | 1 | $0 | 4 | Chief Financial Officer | 20 Dec 2022, 18:49 |
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2022 | 2 | $0 | 4 | Chief Financial Officer | 13 Dec 2022, 19:28 |
| AKRO | Akero Therapeutics, Inc. | 13 Oct 2022 | 3 | -$656,220 | 4 | Chief Financial Officer | 17 Oct 2022, 17:40 |
| AKRO | Akero Therapeutics, Inc. | 13 Sep 2022 | 4 | -$650,548 | 4 | Chief Financial Officer | 15 Sep 2022, 19:57 |
| AKRO | Akero Therapeutics, Inc. | 09 Sep 2022 | 3 | +$9,251 | 4 | Chief Financial Officer | 13 Sep 2022, 21:14 |
| VTYX | Ventyx Biosciences, Inc. | 09 Jun 2022 | 1 | $0 | 4/A | Director | 26 Apr 2023, 20:27 |
| AKRO | Akero Therapeutics, Inc. | 14 Jan 2022 | 3 | -$145,704 | 4 | Chief Financial Officer | 18 Jan 2022, 20:48 |
| AKRO | Akero Therapeutics, Inc. | 21 Dec 2021 | 3 | -$1,499 | 4 | Chief Financial Officer | 23 Dec 2021, 20:03 |
| AKRO | Akero Therapeutics, Inc. | 17 Dec 2021 | 3 | -$48,099 | 4 | Chief Financial Officer | 20 Dec 2021, 15:54 |
| AKRO | Akero Therapeutics, Inc. | 08 Dec 2021 | 1 | $0 | 4 | Chief Financial Officer | 10 Dec 2021, 16:08 |
| AKRO | Akero Therapeutics, Inc. | 01 Nov 2021 | 3 | -$99,002 | 4 | Chief Financial Officer | 03 Nov 2021, 16:15 |
| VTYX | Ventyx Biosciences, Inc. | 20 Oct 2021 | 0 | $0 | 3 | Director | 20 Oct 2021, 18:48 |
| AKRO | Akero Therapeutics, Inc. | 01 Oct 2021 | 3 | -$97,808 | 4 | Chief Financial Officer | 05 Oct 2021, 16:10 |
| AKRO | Akero Therapeutics, Inc. | 01 Sep 2021 | 3 | -$145,426 | 4 | Chief Financial Officer | 03 Sep 2021, 16:38 |
| AKRO | Akero Therapeutics, Inc. | 02 Aug 2021 | 3 | -$66,708 | 4 | Chief Financial Officer | 04 Aug 2021, 17:39 |
| AKRO | Akero Therapeutics, Inc. | 06 Jul 2021 | 3 | -$113,822 | 4 | Chief Financial Officer | 08 Jul 2021, 19:19 |